Cargando…
Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy
BACKGROUND: There are no universally accepted criteria for discontinuing milk oral immunotherapy (MOIT) in patients with persistent cow milk allergy (CMA) and little data are available on predictive risk factors for dropping out from oral immunotherapy (OIT), due to allergic reactions or other reaso...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208286/ https://www.ncbi.nlm.nih.gov/pubmed/35759227 http://dx.doi.org/10.1002/iid3.668 |
_version_ | 1784729710194851840 |
---|---|
author | Benelli, Elisa Trombetta, Andrea Badina, Laura Andrade, Stefanny Zamagni, Giulia Prisco, Antonio Traini, Eugenio Barbi, Egidio Berti, Irene |
author_facet | Benelli, Elisa Trombetta, Andrea Badina, Laura Andrade, Stefanny Zamagni, Giulia Prisco, Antonio Traini, Eugenio Barbi, Egidio Berti, Irene |
author_sort | Benelli, Elisa |
collection | PubMed |
description | BACKGROUND: There are no universally accepted criteria for discontinuing milk oral immunotherapy (MOIT) in patients with persistent cow milk allergy (CMA) and little data are available on predictive risk factors for dropping out from oral immunotherapy (OIT), due to allergic reactions or other reasons. METHODS: We retrospectively reviewed clinical records of patients with persistent severe CMA undergoing MOIT in a tertiary care center hospital to investigate risk factors associated with discontinuation of OIT. Persistent and severe allergy was defined as the history of systemic reactions and any milk protein‐specific IgE level >85 kU/ml. All patients were first admitted for an in‐hospital rush phase eventually followed by an at‐home dose increase. We evaluated the effect of various factors on two primary outcomes: the highest dose of milk ingested during the in‐hospital rush phase and during the home OIT phase. RESULTS: We identified 391 patients, of whom 131 met the inclusion criteria for the retrospective study, 54 females and 77 males. Data of the home OIT phase were available for 104 patients (27%). Regarding the home OIT outcome, an association for having a cow milk avoiding diet was found with reaching a dose below 10 ml during the in‐hospital rush phase (relative risks [RR]: 2.33, confidence interval [CI]: 0.85; 6.42), an age above than 10 years from the time of admission (RR: 3.29, CI: 0.85; 12.73), and a higher total number of reactions occurred during the hospitalization (RR: 1.54, CI: 1.02; 2.32), whereas the presence of respiratory reactions with wheezing (RR: 1.93, CI: 0.49; 7.61) and an IM adrenaline use was related to a higher risk of having an OIT still in progress (RR: 5.47, CI: 0.33; 7.73). CONCLUSIONS: In this cohort of children with persistent CMA undergoing OIT who presented with respiratory reactions with wheezing, the development of anaphylaxis with the need for IM adrenaline, and age above 10 years were predictors of poor long‐term outcome. |
format | Online Article Text |
id | pubmed-9208286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92082862022-06-27 Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy Benelli, Elisa Trombetta, Andrea Badina, Laura Andrade, Stefanny Zamagni, Giulia Prisco, Antonio Traini, Eugenio Barbi, Egidio Berti, Irene Immun Inflamm Dis Original Articles BACKGROUND: There are no universally accepted criteria for discontinuing milk oral immunotherapy (MOIT) in patients with persistent cow milk allergy (CMA) and little data are available on predictive risk factors for dropping out from oral immunotherapy (OIT), due to allergic reactions or other reasons. METHODS: We retrospectively reviewed clinical records of patients with persistent severe CMA undergoing MOIT in a tertiary care center hospital to investigate risk factors associated with discontinuation of OIT. Persistent and severe allergy was defined as the history of systemic reactions and any milk protein‐specific IgE level >85 kU/ml. All patients were first admitted for an in‐hospital rush phase eventually followed by an at‐home dose increase. We evaluated the effect of various factors on two primary outcomes: the highest dose of milk ingested during the in‐hospital rush phase and during the home OIT phase. RESULTS: We identified 391 patients, of whom 131 met the inclusion criteria for the retrospective study, 54 females and 77 males. Data of the home OIT phase were available for 104 patients (27%). Regarding the home OIT outcome, an association for having a cow milk avoiding diet was found with reaching a dose below 10 ml during the in‐hospital rush phase (relative risks [RR]: 2.33, confidence interval [CI]: 0.85; 6.42), an age above than 10 years from the time of admission (RR: 3.29, CI: 0.85; 12.73), and a higher total number of reactions occurred during the hospitalization (RR: 1.54, CI: 1.02; 2.32), whereas the presence of respiratory reactions with wheezing (RR: 1.93, CI: 0.49; 7.61) and an IM adrenaline use was related to a higher risk of having an OIT still in progress (RR: 5.47, CI: 0.33; 7.73). CONCLUSIONS: In this cohort of children with persistent CMA undergoing OIT who presented with respiratory reactions with wheezing, the development of anaphylaxis with the need for IM adrenaline, and age above 10 years were predictors of poor long‐term outcome. John Wiley and Sons Inc. 2022-06-20 /pmc/articles/PMC9208286/ /pubmed/35759227 http://dx.doi.org/10.1002/iid3.668 Text en © 2022 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Benelli, Elisa Trombetta, Andrea Badina, Laura Andrade, Stefanny Zamagni, Giulia Prisco, Antonio Traini, Eugenio Barbi, Egidio Berti, Irene Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy |
title | Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy |
title_full | Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy |
title_fullStr | Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy |
title_full_unstemmed | Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy |
title_short | Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy |
title_sort | risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208286/ https://www.ncbi.nlm.nih.gov/pubmed/35759227 http://dx.doi.org/10.1002/iid3.668 |
work_keys_str_mv | AT benellielisa riskfactorsfordiscontinuingoralimmunotherapyinchildrenwithpersistentcowmilkallergy AT trombettaandrea riskfactorsfordiscontinuingoralimmunotherapyinchildrenwithpersistentcowmilkallergy AT badinalaura riskfactorsfordiscontinuingoralimmunotherapyinchildrenwithpersistentcowmilkallergy AT andradestefanny riskfactorsfordiscontinuingoralimmunotherapyinchildrenwithpersistentcowmilkallergy AT zamagnigiulia riskfactorsfordiscontinuingoralimmunotherapyinchildrenwithpersistentcowmilkallergy AT priscoantonio riskfactorsfordiscontinuingoralimmunotherapyinchildrenwithpersistentcowmilkallergy AT trainieugenio riskfactorsfordiscontinuingoralimmunotherapyinchildrenwithpersistentcowmilkallergy AT barbiegidio riskfactorsfordiscontinuingoralimmunotherapyinchildrenwithpersistentcowmilkallergy AT bertiirene riskfactorsfordiscontinuingoralimmunotherapyinchildrenwithpersistentcowmilkallergy |